COMFORT-I and COMFORT-II Data Review

Video

Jamile Shammo, MD, comments the currently approved treatment options for patients with myelofibrosis and review data from the COMFORT-I and COMFORT-II trials, which evaluates the use of ruxolitinib in MF.

Related Videos
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Video 15 - "Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment"
Rebecca Klisovic, MD
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Sunil Iyer, MD
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Video 14 - "Toxicity Profiles for DTC Guidelines Therapies"
Video 13 - "Understanding the Impact of COSMIC-311 and Sequencing in DTC"